INS and macular retinal edema: An additional clinical challenge is the effect of insulin therapy: intensive glycemic normalization may transiently exacerbate BRB disruption via HIF1α/VEGF-dependent mechanisms, and insulin use is associated with a risk of macular edema — a context that underscores the need for adjuvant strategies beyond glycemic control (24–26).